Clovis Oncology Analysis

Clovis Stock Analysis Notes

About 26.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.13. Clovis Oncology recorded a loss per share of 2.08. The entity had not issued any dividends in recent years. Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. Clovis Oncology, Inc. was incorporated in 2009 and is headquartered in Boulder, Colorado. Clovis Oncology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 413 people. For more info on Clovis Oncology please contact Patrick MA at 303 625 5000 or go to https://www.clovisoncology.com.

Clovis Oncology Investment Alerts

Clovis Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clovis Oncology's market, we take the total number of its shares issued and multiply it by Clovis Oncology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Clovis Profitablity

The company has Profit Margin (PM) of (1.89) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.55) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.55.

Clovis Oncology Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how Clovis Oncology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Clovis shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Clovis Oncology. By using and applying Clovis Stock analysis, traders can create a robust methodology for identifying Clovis entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

If you are still planning to invest in Clovis Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clovis Oncology's history and understand the potential risks before investing.